Proton pump inhibitors may be associated with a greater risk of hip fractures[22] and Clostridium difficile-associated diarrhoea.[23] Patients are frequently administered the drugs in intensive care as a protective measure against ulcers, but this use is also associated with a 30% increase in occurrence of pneumonia.[24]